October 20th 2025
* Generic lenacapavir could be produced for $25 per person per year at scale, according to an analysis presented at IDWeek 2025 in Atlanta.
Comparing clinical features of COVID-19 and seasonal influenza
September 11th 2020The influenza season is going to be here soon, which could make things difficult for a system already taxed by COVID-19. A new report illuminates the similarities and differences between COVID-19 and seasonal influenza.
Mental well-being and families: How COVID-19 has changed things
September 3rd 2020The total psychological toll of the COVID-19 pandemic may not be known for years, but a report sheds some light on how it’s impacted the families of hourly employees in some of the industries hardest hit by the lock-downs.
Let’s proactively stop another public health nightmare!
August 20th 2020This is the critical moment in time for all health care providers to proactively stop this potential public health nightmare by speaking with all parents and adolescents about the absolute need for everyone to receive the influenza vaccine.
As fall approaches, one of the biggest questions is: Can children return to school and be in classroom environments that assure health and well-being for all? Here's how practitioners can help.
Can a RSV vaccine administered during pregnancy be effective in preventing infection during infancy?
August 10th 2020A study looks at whether a vaccine for respiratory syncytial virus (RSV) could be effective in reducing RSV-associated, medically significant lower respiratory tract infections in infants.
Recommendations for compounded hand sanitizers during COVID-19
The COVID-19 pandemic led to a shortage of hand sanitizers and a push to make up the gap with compounded hand sanitizer ensued. Recommendations were released to ensure their efficacy.
Safe return to school: A call to action
As fall approaches, one of the biggest questions is: Can children return to school and be in classroom environments that assure health and well-being for all?
Parents and health care providers need to cheerlead the HPV vaccine for their teens
August 3rd 2020The human papillomavirus (HPV) vaccine is the key to a major public health victory, but the vaccine coverage has been less than effective. A report offers some answer to how parental intent has made an impact.
First 100 million doses of Pfizer, BioNTech COVID-19 vaccine candidate acquired by US government
July 22nd 2020The US government has entered into an agreement to acquire the first 100 doses of a COVID-19 vaccine candidate developed by Pfizer and BioNTech, pending approval by the US Food and Drug Administration.